Drug Shortage Report for AURO-MIRTAZAPINE OD
Report ID | 74174 |
Drug Identification Number | 02299836 |
Brand name | AURO-MIRTAZAPINE OD |
Common or Proper name | Mirtazapine |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | MIRTAZAPINE |
Strength(s) | 45MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-01-31 |
Estimated end date | |
Actual end date | 2019-02-27 |
Shortage status | Resolved |
Updated date | 2019-02-28 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Balaji Srinivasan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-02-28 | French | Compare |
v5 | 2019-02-28 | English | Compare |
v4 | 2019-02-13 | French | Compare |
v3 | 2019-02-13 | English | Compare |
v2 | 2019-02-01 | French | Compare |
v1 | 2019-02-01 | English | Compare |
Showing 1 to 6 of 6